z-logo
Premium
Indoloquinazoline Alkaloids from Araliopsis tabouensis
Author(s) -
Christopher Ezugwu,
Bedir Erdal,
Dunbar Chuck,
Khan Ikhlas A.,
Okunji Christopher O.,
Schuster Brian M.,
Iwu Maurice M.
Publication year - 2003
Publication title -
helvetica chimica acta
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.74
H-Index - 82
eISSN - 1522-2675
pISSN - 0018-019X
DOI - 10.1002/hlca.200390239
Subject(s) - chemistry , plasmodium falciparum , stereochemistry , bioassay , alkaloid , chloride , organic chemistry , malaria , genetics , immunology , biology
Three new indoloquinazolidine‐type alkaloids, 8,13‐dihydro‐2‐methoxyindolo[2′,3′: 3,4]pyrido[2,1‐ b ]quinazolin‐5(7 H )‐one ( 1 ), 8,13‐dihydro‐2‐methoxy‐13‐methylindolo[2′,3′: 3,4]pyrido[2,1‐ b ]quinazolin‐5(7 H )‐one ( 2 ), and 5,8,13,14‐tetrahydro‐2‐methoxy‐14‐methyl‐5‐oxo‐7 H ‐indolo[2′,3′: 3,4]pyrido[2,1‐ b ]quinazolim‐6‐iun chloride ( 3 ) were isolated from Araliopsis tabouensis , together with three known compounds. The structures of the new compounds were determined primarily from 1D‐ and 2D‐NMR analysis. The antimalarial activities of compounds 1 – 5 were evaluated against Plasmodium falciparum D6 and W2 clones. The IC 50 values in antimalarial bioassay for compounds 2 – 5 varied from 1.8 to 4.7 μg/ml.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom